Skip to main content
Veterinary Medicines

Fevaxyn Quatrifel, Injeksjonsvæske, suspensjon, til katt

Not authorised
  • Chlamydia felis, strain Cello, Inactivated
  • Felid herpesvirus 1, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated

Product identification

Medicine name:
Fevaxyn Quatrifel, Injeksjonsvæske, suspensjon, til katt
Active substance:
  • Chlamydia felis, strain Cello, Inactivated
  • Felid herpesvirus 1, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
Target species:
  • Cat
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Chlamydia felis, strain Cello, Inactivated
    1.69
    relative potency
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, Inactivated
    1.39
    relative potency
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain 255, Inactivated
    1.26
    relative potency
    /
    1.00
    millilitre(s)
  • Feline panleucopenia virus, strain CU4, Inactivated
    8.50
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AL02
Authorisation status:
  • Surrendered
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 8127
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 30/03/2022